![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Sigma-aldrich Corporation Saint Louis Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Hyaluronidase, Type VIII, (Product Number H2032), supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2001-364 - Rev 01
This TSE Type CEP, issued on March 18, 2005, remains in force until April 09, 2007, ensuring its reliability within the pharmaceutical industry.
Substance Number 912 associated with this CEP further emphasizes